New research published in Scientific Reports has found that regular exercise paired with omega-3 supplementation can significantly enhance immune function and reduce the severity of chronic apical periodontitis, a type of inflammation that…
Blog
-
Exercise and omega-3s could be the secret to healthier teeth
New research published in Scientific Reports has found that regular exercise paired with omega-3 supplementation can significantly enhance immune function and reduce the severity of chronic apical periodontitis, a type of inflammation that…
Continue Reading
-
TV tonight: a night of ghost-hunting with telly’s funniest siblings | Television & radio
Daisy May and Charlie Cooper’s NightWatch
9.30pm, BBC Two
Daisy May Cooper is late meeting her brother Charlie – she’s been busy stocking up in a crystal shop, before they set off on a tour of the UK’s spookiest places. They start with a…
Continue Reading
-
Croxley Green wine scam victim’s warning as fraudsters jailed
Nicola HaselerHertfordshire
BBC/Nicola HaselerTerry Fleming, 81, invested £40,000 over two years in what he thought was a profitable scheme A pensioner who ploughed £40,000 into a fraudulent wine investment scheme has warned others not to fall for similar scams after three men were jailed.
Terry Fleming, 81, from Croxley Green, Hertfordshire, said he invested the money over two years believing he would make a profit, but eventually had to sell the bottles at a considerable loss.
Three men who stole at least £6m from 41 victims in the scheme were given prison terms to at St Albans Crown Court on Friday.
Mr Fleming said the scam “sounded believable” but the men only “cared about how much money they were going to make”.
Benjamin Cazaly, 43, of Coach House, Orpington, south-east London, was jailed for six and a half years; Dominic D’Sa, 46, of Oxford Avenue, Wimbledon, south-west London, for four and a half years; and Gregory Assemakis, 40, of Plaistow Grove, Bromley, south-east London, for three and a half years.
They had been found guilty of fraudulent trading in August.
Cazaly founded Imperial Wines of London in 2008.
It claimed to be a family-run investment house with offices in Paris and Hong Kong.
In reality, it was a call centre in an office building in Groveland Court, London, which was raided by trading standards in November 2018.
An investigation by Hertfordshire Trading Standards found £37m passed through Imperial Wine & Spirits Merchants’ accounts during the 10 years it was trading.
Hertfordshire County CouncilThe company had the mantra “no means yes” written on the wall The mantra “no means yes” was written on the wall, and they used films such as The Wolf of Wall Street to learn manipulation tricks.
Cold callers used fake names and followed scripts – found when the office was raided – to persuade pensioners to hand over their money.
Victims were sent glossy brochures that used logos from the Daily Telegraph and the Financial Times without permission.
Hertfordshire County Council said the jury was played a recording where a confused woman was asked for payment card details despite not knowing what a card was or who she banked with.
It said the long-running scam saw pensioners convinced to spend their life savings on wine investments which had vastly inflated prices.
Investors were told the company did not make money unless the wine was sold at a profit.
Mr Fleming said: “It sounded believable.
“It didn’t seem like you were paying a small price and getting a huge return, it would be an average purchase price and a reasonable profit selling price.”
But staff from Imperial Wines of London kept contacting him.
“They offered me better and better deals,” he said.
“Instead of just a slight profit, these were really good wines that were going to make a lot of money. I said ‘no, no, no’ and they kept coming back trying to sell me more and more wine.”
What Mr Fleming didn’t realise was that the bottles he was paying £2,000 for were only worth £400. In the end he had to sell them at a loss.
“They sold some of it for me at a loss but some of the wine just disappeared,” he said.
“I just gave up in the end. All they cared about was how much money they were going to make. “
Hertfordshire County CouncilVictims were overcharged in the wine investment scheme, sometimes by 400%, National Trading Standards said Trish Burls, from National Trading Standards, said: “Victims in this case lost thousands of pounds through a co-ordinated scam of lies, deceit and manipulation.
“The criminals exploited people’s passion and enthusiasm, preying on them to invest while stripping many of their life savings and causing significant emotional distress.”
Ajanta Hilton, executive member for community safety at Hertfordshire County Council, added: “The stories of those targeted with this investment scam are devastating.
“I’d like to thank them for their bravery in telling their stories so that these callous criminals could be brought to justice.”
Mr Fleming said he is speaking out to prevent other people from falling for similar scams.
“However smooth and nice they seem, they’re not,” he said.
“The nicer they seem, the worse they are.
“A lot of people I know didn’t cope, and it must have been terrible for them because their lives have been ruined.
Continue Reading
-
The musician with millions of Spotify listeners
Olivia OsbyLiam McCay is possibly best known as Sign Crushes Motorist, although he has released music under a variety of names Liam McCay was driving down Sunset Boulevard in Los Angeles with a friend from Ireland when it set in just how different…
Continue Reading
-
Over 140,000 candidates sit nationwide entry test
MDCAT examinations, Dow Univeristy, Karachi Sindh October 26 2025 Photo: Our Correspondent
The Medical and Dental College Admission Test (MDCAT) 2025…
Continue Reading
-
Are Recent Gains in Bank of China Shares Supported by Strong Valuation in 2025?
If you have been watching Bank of China’s stock, you are not alone. Whether you are considering buying in, holding, or wondering if it is time to lock in some profits, the last few years have given you plenty to think about. With share prices rising more than 23.8% in the past year and an outstanding 163.2% over the last five years, Bank of China has outperformed many expectations. Just this past week, shares nudged up another 2.6%, echoing a positive sentiment that has been building among investors.
Some of this optimism is tied to ongoing global financial shifts, where Chinese banks are seeing stronger capital inflows and a broad wave of strategic government support. Recent headlines highlight regulatory efforts aimed at reinforcing the stability of major banks, and Bank of China stands to benefit from both its size and its international footprint. These factors are changing how many investors perceive risk in the Chinese banking sector. They are also making those return numbers even more interesting.
With a value score of 5 out of a possible 6 checks for undervaluation, Bank of China already looks compelling compared to its peers. Next, let’s break down how that score came together using classic valuation approaches. As you will see, there may be an even more insightful way to look at the company’s worth.
Why Bank of China is lagging behind its peers
The Excess Returns valuation model measures how much return a company generates above the cost of its equity. This makes it a useful way to assess whether shareholders are getting a worthwhile reward for their investment risk. For Bank of China, this approach focuses on several key metrics drawn from forward-looking analyst expectations and historical performance.
Currently, Bank of China has a book value of HK$8.19 per share and a stable earnings per share (EPS) estimate of HK$0.75, based on a consensus of 14 analysts. The cost of equity is calculated at HK$0.78 per share, resulting in a modest excess return of HK$-0.02 per share. The company’s average return on equity is a solid 8.26%, with forecasts projecting a stable book value moving up to HK$9.11 per share, sourced from 11 analyst estimates.
Applying the Excess Returns model to these figures suggests an intrinsic value significantly higher than the current market price. The model estimates Bank of China’s stock to be approximately 53.8% undervalued. This result suggests the market may be underestimating the company’s capacity to generate returns on equity, especially relative to its peers and the industry average.
Continue Reading
-
How Analyst Perspectives Are Shaping the Evolving Story for Bank Pekao
Bank Polska Kasa Opieki has recently seen a slight decrease in its consensus analyst price target, shifting from PLN 210.03 to PLN 207.78. This change comes as analysts weigh the bank’s robust historical revenue growth and stable asset quality, while also considering uncertainties brought on by evolving market conditions. Stay tuned to discover how you can continue monitoring key updates and shifts in the bank’s investment outlook.
Recent analyst activity reflects a reassessment of Bank Polska Kasa Opieki’s stock, factoring in both the company’s historical strengths and shifting market sentiment.
🐂 Bullish Takeaways
-
Analysts have previously rewarded Bank Polska Kasa Opieki for strong execution, consistent historical growth in revenue, and maintaining stable asset quality.
-
Positive mentions have often cited disciplined cost control and transparency, which support the bank’s resilient operating profile.
-
Some analysts acknowledge that while upside potential exists, much of it may be priced in at current valuation levels. This warrants a more balanced view going forward.
🐻 Bearish Takeaways
-
Oddo BHF downgraded Bank Polska Kasa Opieki to Neutral from Outperform on October 22, 0025, assigning a price target of PLN 200. This signals a more cautious stance on near-term upside.
-
The downgrade reflects elevated concerns about the bank’s valuation and the potential that recent market optimism may have already been factored into the share price.
Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there’s more to the story. Head to the Simply Wall St Community to discover more perspectives or begin writing your own Narrative!
WSE:PEO Community Fair Values as at Oct 2025 -
Bank Polska Kasa Opieki S.A. has announced a Special/Extraordinary Shareholders Meeting, which will take place on November 6, 2025, at 10:00 Central European Standard Time. The gathering is expected to address key strategic decisions for the bank’s future.
-
Analyst consensus price targets for Bank Polska Kasa Opieki have slightly declined, reflecting both steady performance fundamentals and increased market uncertainty.
-
Recent shifts in analyst outlooks, including a rating downgrade from Oddo BHF, highlight a cautious approach to the bank’s medium-term prospects amid valuation and market sentiment concerns.
-
The consensus analyst price target has decreased slightly from PLN 210.03 to PLN 207.78.
-
The discount rate has edged up marginally from 9.44% to 9.45%.
-
The revenue growth expectation has risen from 1.99% to 2.68%.
-
The net profit margin has decreased from 41.04% to 40.38%.
-
The future P/E ratio has declined modestly from 10.61x to 10.46x.
Continue Reading
-
-
Assessing Valuation After Launch of 5-Base Sequencing and Constellation Platform Advances
Illumina (ILMN) is capturing attention following the debut of its proprietary 5-base sequencing solution and impressive results from GeneDx’s pilot of the constellation platform. Both developments were showcased at the American Society for Human Genetics meeting.
See our latest analysis for Illumina.
Illumina’s shares have seen a notable rebound in recent weeks, logging a 9% gain over the last month as investors responded to a flurry of new product launches and encouraging partnerships. However, the stock is still down 24% on a year-to-date share price return basis, and its one-year total shareholder return stands at -29%, reflecting the longer road ahead for a sustained turnaround.
If Illumina’s fresh innovation streak has you watching the sector, it could be the perfect moment to browse other breakthroughs. See the full list of healthcare movers in See the full list for free.
But with Illumina’s fundamentals still recovering and shares trading below analyst price targets, investors are left to consider: is there real upside from here, or is future growth already priced into the stock?
Illumina’s narrative-based fair value estimate lands at $111.95, which is about $12 above the last close of $100.11. This gap spotlights perceived upside in the current share price versus analyst consensus.
Ongoing innovation, multiomics expansion, and operational efficiency are enhancing gross margins and creating new growth opportunities. Strategic expansion into multiomics, notably the planned acquisition of SomaLogic and integration of proteomics capabilities, creates incremental growth opportunities by increasing the breadth of Illumina’s data and platform offerings, contributing to future revenue and operating margin expansion.
Read the complete narrative.
Curious which bold, forward-looking financial shifts power this valuation? The answer lies in a mix of aggressive margin bets, platform scale-up strategies, and the kind of future earnings moves you might not expect. The most debated projections are all embedded here. Click through to discover what really drives this narrative.
Result: Fair Value of $111.95 (UNDERVALUED)
Have a read of the narrative in full and understand what’s behind the forecasts.
However, persistent funding constraints and mounting regulatory hurdles in China still pose meaningful risks that could alter Illumina’s long-term trajectory.
Find out about the key risks to this Illumina narrative.
If you see things differently or want to run your own numbers, it’s quick and easy to craft a unique Illumina outlook in just minutes with Do it your way.
Continue Reading
-
Breaking Down Valuation After Strong Year-to-Date Share Price Gains
Uranium Energy (UEC) shares climbed 3% at the open, catching attention after a strong performance this year. With uranium prices in focus across the market, investors are watching to see if this momentum can continue.
See our latest analysis for Uranium Energy.
Uranium Energy’s share price has charged ahead this year, notching a year-to-date gain of 79.3%, and its 3-year total shareholder return sits at an impressive 223.7%. Recent volatility has been part of a broader surge in uranium equities, as shifting sentiment and renewed interest in the sector have pushed momentum higher instead of fading.
If the strength in uranium has you curious, it might be the perfect moment to expand your search and discover fast growing stocks with high insider ownership
The question now is whether Uranium Energy’s rally still leaves the shares undervalued, or if the current price already reflects all of the company’s future growth potential. Is there genuine upside left for buyers, or is the market a step ahead?
At a price-to-book ratio of 6.7x, Uranium Energy shares are trading at a premium to both industry peers and the broader sector. The last close price of $13.66 positions the stock in expensive territory on this metric, prompting a closer look at whether such a valuation holds up given where the company stands today.
The price-to-book ratio measures the market value of a company’s equity relative to its net assets. For resource-focused companies like Uranium Energy, where asset values play a crucial role, this multiple provides an essential snapshot for investors assessing whether the stock’s market value makes sense given its asset base.
Uranium Energy’s price-to-book of 6.7x is above the average for its peer group (5.8x) and far exceeds the broader US oil and gas industry average of 1.4x. This reflects a hefty premium. If the market were to move toward a lower, more typical level, it would represent a significant re-rating lower for the stock.
See what the numbers say about this price — find out in our valuation breakdown.
Result: Price-to-Book of 6.7x (OVERVALUED)
However, if uranium prices retreat or investor enthusiasm subsides, Uranium Energy’s premium valuation could quickly come under pressure and alter the narrative ahead.
Find out about the key risks to this Uranium Energy narrative.
Switching lenses from asset multiples to our DCF model, Uranium Energy appears to be trading almost exactly at its calculated fair value. While the price-to-book ratio signals overvaluation, the discounted future cash flows suggest UEC could be fairly priced. Will the market follow the fundamentals, or do investors still expect more upside?
Continue Reading
